Author:
Karunakaran V.,Johnston J. R.
Abstract
SUMMARYPrimary genes, designated asNYSA, NYSD, NYSE, NYSF(dominant) andnysB,nysC(recessive) are responsible for resistance to nystatin ranging from 30 to 80 u/ml. A dominant modifier gene increases the resistance conferred byNYSFfrom 80 to 140 u/ml and a recessive modifier gene enhances resistance due toNYSAby 20 u/ml (from 40 to 60 u/ml). One nystatin-resistant mutant is apparently cytoplasmic and this ‘mutation’ suppresses specifically the action of modifying factors which increase the level of resistance conferred by theNYSAgene. Interaction resulting in additive levels of resistance is shown by geneNYSDin combination with each of the genesnysB,nysCandNYSE. A model of step-wise increases in resistance due to polygenic primary genes and nuclear and cytoplasmic modifying factors is proposed.
Subject
Genetics,General Medicine
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献